Luxiq (betamethasone valerate foam) is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.

Note: For proper dispensing of foam, can must be inverted.

For application to the scalp invert can and dispense a small amount of Luxiq (betamethasone valerate foam) onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. Apply twice daily, once in the morning and once at night.

As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.

Luxiq (betamethasone valerate foam) should not be used with occlusive dressings unless directed by a physician.

Luxiq (betamethasone valerate foam) is supplied in 150 gram (NDC 63032-021-01), 100 gram (NDC 63032-021-00) and 50 gram (NDC 63032-021-50) aluminum cans.

Store at controlled room temperature 68-77°F (20-25°C).

WARNING

FLAMMABLE. AVOID FIRE, FLAME OR SMOKING DURING AND IMMEDIATELY FOLLOWING APPLICATION. Keep out of reach of children. Contents under pressure. Do not puncture or incinerate container. Do not expose to heat or store at temperatures above 120°F (49°C).

Manufactured for Stiefel Laboratories, Inc., Coral Gables, FL 33134, USA. For additional information: 1-888-500-DERM or visit www.luxiq (betamethasone valerate foam) .com. FDA Rev date: 7/11/2006

Last reviewed on RxList: 9/29/2008
This monograph has been modified to include the generic and brand name in many instances.